SC
LLY icon

Scotia Capital’s Eli Lilly LLY Stock Holding History

Scotia Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100,000
Closed -$7.36M – 796
2016
Q4 		$7.36M Buy
+100,000
New +$7.45M 0.12% 124

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Scotia Capital's LLY Position: Q1 2026 in Review

Scotia Capital reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $10.2M and leaving 86,840 shares worth $79.9M. The position accounts for 0.33% of the portfolio, ranked #59.

Scotia Capital first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $104M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Scotia Capital held 86,840 shares of Eli Lilly worth $79.9M as of Q1 2026.
  • Scotia Capital sold 10,110 Eli Lilly shares in Q1 2026, an estimated $10.2M.
  • Eli Lilly made up 0.33% of Scotia Capital's portfolio in Q1 2026, its #59 holding.
  • Scotia Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Scotia Capital's Eli Lilly position peaked at $104M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.